Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats
Rosiglitazone is an agonist of peroxisome proliferator-activated receptor- (PPAR-) γ that is principally associated with insulin action. The exact mechanisms underlying its insulin-sensitizing action are still not fully elucidated. It is well known that adiponectin mostly secreted in adipose tissue...
Saved in:
| Main Authors: | Jia Li, Yao-Ming Xue, Bo Zhu, Yong-Hua Pan, Yan Zhang, Chunxia Wang, Yuhao Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2018/4627842 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the Effectiveness of Insulin Sensitizing Agents Metformin and Rosiglitazone in PCOS
by: Rıfat Emral, et al.
Published: (2008-06-01) -
Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
by: Natalie L. Rasgon, et al.
Published: (2010-01-01) -
Coordinate Transcriptomic and Metabolomic Effects of the Insulin Sensitizer Rosiglitazone on Fundamental Metabolic Pathways in Liver, Soleus Muscle, and Adipose Tissue in Diabetic db/db Mice
by: Sabrina Le Bouter, et al.
Published: (2010-01-01) -
Effect of adiposity on tissue-specific adiponectin secretion.
by: James Reneau, et al.
Published: (2018-01-01) -
Adiponectin and insulin: molecular mechanisms of metabolic disorders
by: E. G. Uchasova, et al.
Published: (2020-10-01)